Therefore, surveillance of LASP1 phosphorylation status in CML patients may serve as a new read-out in CML patients under TKI treatment; appropriate studies are underway. This evidence concerns the gene LASP1 and chronic myelogenous leukemia, BCR-ABL1 positive.